The immune system has to cope with a wide range of irregularly shaped pathogens that can
actively move (eg, by flagella) and also dynamically remodel their shape (eg, transition from …

Dendritic cell (DC)‐based cancer immunotherapy has exhibited remarkable clinical
prospects because DCs play a central role in initiating and regulating adaptive immune …

Dendritic cells (DCs) are the primary antigen-presenting cells and play key roles in the
orchestration of the innate and adaptive immune system. Targeting DCs by nanotechnology …

Nanovaccine‐based immunotherapy (NBI) has the ability to initiate dendritic cell (DC)‐
mediated tumor‐specific immune responses and maintain long‐term antitumor immune …

Nanoparticles (NPs) have been gaining prominence as delivery vehicles for modulating
immune responses to improve treatments against cancer and autoimmune diseases …

Poly-L-lactic acid (PLLA) fillers correct cutaneous volume loss by stimulating fibroblasts to
synthesize collagen and by augmenting the volume. PLLA triggers the macrophage-induced …

Peptides are versatile building blocks for the fabrication of various nanostructures that result
in the formation of hydrogels and nanoparticles. Precise chemical functionalization promotes …

Dendritic cells (DCs), as the most powerful antigen presenting cells, play a critical role in
regulating immune response and anti-tumor process. However, the immunosuppressive …

Nature is an important inspirational source for scientists, and presents complex and elegant
examples of adaptive and intelligent systems created by self-assembly. Significant effort has …

Immunotherapies have significantly improved cancer patient survival, but response rates are
still limited. Thus, novel formulations are needed to expand the breadth of immunotherapies …